Archives for the 'feature2' Category
Researchers identified three proteins, called Toll-Like Receptors (TLRs), that can cause the immune system to turn against the body.
3 July 2009 |
Blog, feature2 |
CombinatoRx has signed an all-stock merger agreement with Neuromed.
2 July 2009 |
Blog, feature2 |
The multi-year agreement will focus on the skin rejuvenation segment of the marketplace.
2 July 2009 |
Blog, feature2 |
Applied Spine Technologies has received permission from the FDA to restart a clinical trial of Stabilimax NZ.
1 July 2009 |
Blog, feature2 |
CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.
30 June 2009 |
Blog, feature2 |
Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard.
26 June 2009 |
Blog, Member Spotlight, Sentinel 2, feature2 |
The Iselin, NJ-based company was recognized for its REPEL-CV Anti-Adhesion Barrier.
25 June 2009 |
Blog, Member Spotlight, Sentinel 2, feature2 |
The money will allow CNS Response, based in Costa Mesa, Calif., to complete an upcoming depression study.
25 June 2009 |
Blog, Member Spotlight, Sentinel 1, feature2 |
In clinical trials, Cambia provided statistically significant onset of relief of migraine pain within 15 to 30 minutes.
24 June 2009 |
Blog, Sentinel 2, Uncategorized, feature2 |
A new genetic discovery could lead to easier detection of colorectal cancer.
19 June 2009 |
Blog, Uncategorized, feature2 |
